Zimmer Biomet Holdings, Inc. (NYSE:ZBH) will begin trading ex-dividend on December 24, 2020. The quarterly dividend payment of $ 0.24 per share is scheduled to be paid on January 29, 2021. The dividend yield based on the latest trading day closing price was 0.64 percent. To secure the dividend payout, investors must buy the stock prior to the ex-dividend date of December 24, 2020.
|Date||Symbol||Company Name||Period||Value||Record Date||Payment Date||Exchange Date||displaynhide||day_navigation||week_navigation||month_navigation||Link||div_value|
Zimmer Biomet Holdings, Inc. recently reported third quarter financial results on November 6, 2020, before market open, manufacturer of musculoskeletal healthcare products and solutions announced income for the third quarter of $ 1.81 per share, from the revenue of $ 1,929.00 million. The quarterly earnings developed 2.26 percent while revenues raised 1.96 percent compared with the same quarter last year.
Street analysts expected Zimmer Biomet Holdings, Inc. recently reported third quarter financial results on November 6, 2020, before market open, manufacturer of musculoskeletal healthcare products and solutions to report income of $ 1.07 per share on revenue of $ 1710.47 million for the third quarter. The bottom line results beat street analysts by $ 0.74 or 69.16 percent, at the same time, top line results outshined analysts by $ 218.53 million or 12.78 percent.
Shares of Zimmer Biomet Holdings, Inc. traded up $ 2.23 or 1.50 percent on Tuesday, reaching $ 150.83 with volume of 1.00 million shares. Zimmer Biomet Holdings, Inc. has traded high as $ 151.70 and has cracked $ 146.20 on the downward trend
According to the previous trading day, closing price of $ 150.83, representing a 99.81 % increase from the 52 week low of $ 74.37 and a 10.02 % decrease over the 52 week high of $ 165.15.
The company has a market capital of $ 31.26 billion and is part of the Healthcare sector and Medical Devices industry.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T.